$-0.02
(Market cap
$569 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$0
-
Face value
--
-
Shares outstanding
41,900,000
10 Years Aggregate
CFO
$-305.62 Mln
EBITDA
$-463.10 Mln
Net Profit
$-475.47 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
ChemoCentryx (CCXI)
| -- | 0.2 | -- | -- | -- | -5.3 | 8.1 |
|
BSE Sensex*
| -9.3 | 2.0 | 0.1 | -5.7 | 6.6 | 8.0 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
|---|---|---|---|---|---|---|---|
|
ChemoCentryx (CCXI)
| -41.2 | 56.6 | 262.5 | 82.8 | -19.6 | -8.6 | 18.6 |
|
S&P Small-Cap 600
| 25.3 | 9.6 | 20.9 | -9.7 | 11.7 | 24.7 | -3.4 |
|
BSE Sensex
| 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 | -5.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
ChemoCentryx (CCXI)
|
10.3 | 569.3 | 0.0 | 0.5 | -- | -- | -- | 0.0 |
| 4.3 | 100.4 | 5.4 | -24.6 | 0.0 | -203.5 | -- | 9.6 | |
| 10.5 | 506.5 | 334.3 | 104.7 | 37.3 | 31.8 | 4.9 | 1.5 | |
| 144.0 | 94,143.8 | 40,653.0 | 5,961.0 | 13.6 | 13.4 | 17 | 2.5 | |
| 123.8 | 147,747.0 | 14,986.7 | 3,054.1 | 48.8 | 0.1 | 31 | 17.6 | |
| 29.2 | 8,773.6 | 354.7 | -1,216.5 | -83.2 | -- | -- | 0.0 | |
| 1.6 | 135.0 | 15.3 | -34.8 | -226.3 | -113.6 | -- | 3.9 | |
| 15.5 | 4,161.9 | 2,631.8 | -198.4 | 2.3 | -- | -- | 1.4 | |
| 41.7 | 25,129.3 | 2,517.0 | -5.0 | -1.1 | 4 | -- | 7.7 | |
| 29.9 | 759.9 | 50.5 | -53.0 | -73.0 | -129.6 | -- | 14.7 |
Shareholding Pattern
View DetailsAbout ChemoCentryx (CCXI)
Churchill Capital Corp XI does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company... was incorporated in 2025 and is based in New York, New York. Read more
-
Founder, Pres, CEO & Chairman
Dr. Thomas J. Schall Ph.D.
-
Founder, Pres, CEO & Chairman
Dr. Thomas J. Schall Ph.D.
-
Headquarters
New York, NY
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for ChemoCentryx (CCXI)
What is the current share price of ChemoCentryx Inc (CCXI) Today?
The share price of ChemoCentryx Inc (CCXI) is $10.31 (NASDAQ) as of 18-Jun-2026 16:00 EDT. ChemoCentryx Inc (CCXI) has given a return of --% in the last 1 years.
What is the current PB & PE ratio of ChemoCentryx Inc (CCXI)?
Since, TTM earnings of ChemoCentryx Inc (CCXI) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
--
|
--
|
|
2021
|
-19.34
|
8.91
|
|
2020
|
-73.83
|
10.60
|
|
2019
|
-40.63
|
34.16
|
|
2018
|
-14.37
|
37.01
|
What is the 52 Week High and Low of ChemoCentryx Inc (CCXI)?
The 52-week high and low of ChemoCentryx Inc (CCXI) are Rs 11.13 and Rs 10.14 as of 19-Jun-2026.
What is the market cap of ChemoCentryx Inc (CCXI)?
ChemoCentryx Inc (CCXI) has a market capitalisation of $ 569 Mln as on 12-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in ChemoCentryx Inc (CCXI)?
Before investing in ChemoCentryx Inc (CCXI), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.